Missing/wrong data?
Log in to edit
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
scientific article
Author/s
author: Daniel Podzamczer, Hans-Jürgen Stellbrink, Federico Pulido, Chloe Orkin, François Raffi
Work details
Publication date
January 8, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.